Pharma Industry Reputation: What Is At Stake With COVID-19?

 
• By Ben Comer
  
IV2008_Pharma-Reputation_1200.jpg
Industry reputations have much to gain – or lose – from the ongoing response to COVID-19
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Leadership

More from In Vivo